Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

SPAROBOPAN Project (Spanish Registry of Robotic Pancreatic Surgery)

NCT06899269 · Hospital General Universitario de Alicante · Updated 27 March 2025

What is being tested
robotic resection with Da Vinci Xi
For
Robotic Surgical Procedures; Pancreatic Diseases
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 225 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 April 2025, ends 30 June 2029. Registered 27 March 2025.
Results
None posted yet.

In the researchers' words

Pancreatic robotic surgery (PRS) has moved from an almost testimonial procedure to a moment of expansion that is not yet clearly defined. In the pioneering centres, the results achieved are superior to those of open surgery. At present, it is not known how many centres perform CRP, what type of operations they perform, what percentage of the total number of pancreatic operations CRP represents and what results are obtained. The aim of our project is to establish a national multicentre registry of robotic pancreatic surgery that will allow us to answer all these questions. Methodology: This is a one-year prospective multicentre registry involving all general and digestive surgery units in Spain that have a DaVinci robotic platform and wish to participate and perform robotic pancreatectomies. All adult patients undergoing robotic pancreatectomy at participating Spanish centres who meet the inclusion criteria will be included. The registry will be open until 31 March 2026 to include post-operative morbidity and mortality at 90 days. The number of pancreatic surgeries performed in that centre during the same period will be counted to determine the percentage of robotic pancreatic surgery per centre. Intraoperative complications will be measured according to the Satava classification modified by Halls et al. Postoperative complications will be classified according to the…
ClinicalTrials.gov, NCT06899269